Kotak Equities Bullish on Indian Pharma Amid US Tariff Concerns
Kotak Institutional Equities remains positive about the Indian pharmaceutical sector, even as US tariff uncertainties loom. They believe leading companies ...
Kotak Institutional Equities remains positive about the Indian pharmaceutical sector, even as US tariff uncertainties loom. They believe leading companies ...
Neuland Laboratories, a Hyderabad-based pharmaceutical company, has delivered massive returns in 13 years. In 2010, its share price was around ...
Suven Pharmaceuticals' shares surged 14% to Rs 1,328.20 on the BSE during Thursday's trade. This rise is due to heavy ...
HSBC has analyzed the potential impact of a 10% tariff on Indian pharmaceutical companies' earnings per share (EPS) for the ...
India plans to increase its pharmaceutical exports tenfold, targeting $350 billion by 2047. The country will focus on specialty generics, ...
On February 10, 2025, the Nifty Pharma index fell by 2%, hitting an intraday low of 21,634.75. Analysts cited three ...